Francisco, Jenelyn .
HRN: 28-62-35 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/06/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/06/2026
03/12/2026
IV
750mg
OD
DM Foot Right
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: